share_log

Stifel Maintains Hold on MEI Pharma, Raises Price Target to $10

Benzinga ·  May 12, 2023 09:37

Stifel analyst Stephen Willey maintains MEI Pharma (NASDAQ:MEIP) with a Hold and raises the price target from $0.5 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment